Tear Based Sample Collection Breast Cancer Detection

Tear Based Sample Collection for Breast Cancer Detection

This study aims to collect tear samples from 50 women who have been recently diagnosed with breast cancer.

Namida Lab, Inc. is a biotechnology company located in Fayetteville, AR, with a certified, high-complexity CLIA lab. In January of 2021, Namida Lab, Inc. completed the analytical and clinical validation of a tear-based biological screening test for breast cancer based on proteins from tears. The validation process was carried out manually and now needs to be conducted on the Hamilton StarPlus automated ELISA system. To complete the robot validation, Namida Lab, Inc. needs fifty (50) tear samples collected from women recently diagnosed with breast cancer but who have not undergone any treatment.

Inclusion Criteria:

• Individual is an adult woman and has recently been diagnosed with breast cancer.

Exclusion Criteria:

• Individual is excluded if they have already started treatment for the breast cancer diagnosis.
• Age less than 18 or more than 100 years.